XML 16 R6.htm IDEA: XBRL DOCUMENT v3.22.2.2
Statements Of Changes In Redeemable Convertible Preferred Stock And Stockholders' Equity - USD ($)
Total
Cumulative effect of adoption of accounting standard
Series A Redeemable Convertible Preferred Stock
Series A-2 Redeemable Convertible Preferred Stock
Series A-3 Redeemable Convertible Preferred Stock
Common Stock
Additional Paid-in Capital
Additional Paid-in Capital
Cumulative effect of adoption of accounting standard
Accumulated Deficit
Accumulated Deficit
Cumulative effect of adoption of accounting standard
Accumulated Other Comprehensive Income/ (Loss)
Balance (in shares) at Dec. 31, 2020     121,735,303 22,047,361 31,209,734 1,256,609          
Balance at Dec. 31, 2020 $ (69,374,941) $ (1,537,274) $ 35,047,435 $ 7,685,865 $ 10,887,449 $ 126 $ 8,206,938 $ (2,277,332) $ (77,582,005) $ 740,058 $ 0
Issuance of common stock (in shares)           7,441,650          
Issuance of common stock 114,551,315         $ 744 114,550,571        
Exercise of stock options (in shares)           197,041          
Exercise of stock options 661,657         $ 20 661,637        
Stock-based compensation 4,309,356           4,309,356        
Issuance of Series A redeemable preferred stock upon exercise of warrants (in shares)     145,000                
Issuance of Series A redeemable preferred stock upon exercise of warrants 0   $ 1,450                
Conversion of preferred stock into common stock, Temporary equity (in shares)     (121,880,303) (22,047,361) (31,209,734)            
Conversion of preferred stock into common stock     $ (35,048,885) $ (7,685,865) $ (10,887,449)            
Conversion of preferred stock into common stock (in shares)           10,144,041          
Conversion of preferred stock into common stock 53,622,199         $ 1,014 53,621,185        
Conversion of convertible debt into common stock (in shares)           3,669,010          
Conversion of convertible debt into common stock 30,252,056         $ 367 30,251,689        
Exercise of warrants (in shares)           2,896          
Change in unrealized loss on marketable available-for-sale securities 702                   702
Net loss (35,375,910)               (35,375,910)    
Balance (in shares) at Sep. 30, 2021     0 0 0 22,711,247          
Balance at Sep. 30, 2021 97,109,160   $ 0 $ 0 $ 0 $ 2,271 209,324,044   (112,217,857)   702
Balance (in shares) at Jun. 30, 2021           22,628,007          
Balance at Jun. 30, 2021 109,909,420         $ 2,263 207,480,819   (97,570,745)   (2,917)
Exercise of stock options (in shares)           83,240          
Exercise of stock options 214,802         $ 8 214,794        
Stock-based compensation 1,628,431           1,628,431        
Change in unrealized loss on marketable available-for-sale securities 3,619                   3,619
Net loss (14,647,112)               (14,647,112)    
Balance (in shares) at Sep. 30, 2021     0 0 0 22,711,247          
Balance at Sep. 30, 2021 97,109,160   $ 0 $ 0 $ 0 $ 2,271 209,324,044   (112,217,857)   702
Balance (in shares) at Dec. 31, 2021     0 0 0 22,828,904          
Balance at Dec. 31, 2021 83,760,667   $ 0 $ 0 $ 0 $ 2,283 211,498,827 $ (2,300,000) (127,743,455) $ 700,000 3,012
Issuance of common stock (in shares)           3,184,900          
Issuance of common stock $ 5,145,409         $ 319 5,145,090        
Exercise of stock options (in shares) 362,886         12,890          
Exercise of stock options $ 33,255         $ 1 33,254        
Stock-based compensation 4,392,388           4,392,388        
Cashless exercise of options for common stock (in shares)           51,757          
Cashless exercise of options for common stock 0         $ 5 (5)        
Change in unrealized loss on marketable available-for-sale securities (3,012)                   (3,012)
Net loss (45,613,174)               (45,613,174)    
Balance (in shares) at Sep. 30, 2022     0 0 0 26,078,451          
Balance at Sep. 30, 2022 47,715,533   $ 0 $ 0 $ 0 $ 2,608 221,069,554   (173,356,629)   0
Balance (in shares) at Jun. 30, 2022           22,893,551          
Balance at Jun. 30, 2022 55,852,681         $ 2,289 214,486,976   (158,627,249)   (9,335)
Issuance of common stock (in shares)           3,184,900          
Issuance of common stock 5,145,409         $ 319 5,145,090        
Stock-based compensation 1,437,488           1,437,488        
Change in unrealized loss on marketable available-for-sale securities 9,335                   9,335
Net loss (14,729,380)               (14,729,380)    
Balance (in shares) at Sep. 30, 2022     0 0 0 26,078,451          
Balance at Sep. 30, 2022 $ 47,715,533   $ 0 $ 0 $ 0 $ 2,608 $ 221,069,554   $ (173,356,629)   $ 0